Stem Cell

California Stem Cell Report
Asterias Stock Price Jumps Nearly 13 Percent Today Following hESC Therapy News

Asterias Stock Price Jumps Nearly 13 Percent Today Following hESC Therapy News

The California stem cell agency and Asterias Biotherapeuticstoday picked up a modicum of news coverage in connection with an advance on a spinal injury therapy that was once hailed as historic.


The news about the Menlo Park, Ca., firm’s clinical trial received major attention in the San Francisco Chronicle and more modest coverage in...

California Stem Cell Report
California’s Stem Cell Trial for Spinal Cord Injury Moves Forward

A California firm, backed by $14.3 million in state cash, today announced that it has received a federal go-ahead to advance its clinical trial involving a human embryonic (hESC) therapy for cervical spinal cord injury.


Asterias Biotherapeutics, Inc., of Menlo Park, said in a press release that it is currently selecting clinical trial...

California Stem Cell Report
Earthquakes and Scientific Research: California’s Exposure to Damage

Earthquakes and Scientific Research: California’s Exposure to Damage

The 6.1 earthquake today in Northern California once again demonstrated the vulnerability of scientific research in the Golden State to disruption by tremor.


As of Sunday morning, no research institutions – stem cell or otherwise -- reported damage from the quake. However, it was still early in the process of assessing the full impact of...

California Stem Cell Report
Stem Cell Blowback on the Ice Bucket Challenge

Virulent opposition to research involving human embryonic stem cells is surfacing anew in the wake of the vast attention attracted by the Ice Bucket Challenge.


Sarah Pulliam Bailey wrote on Religion News Service that the objections have “gone viral” on the Internet because the beneficiary of the watery fundraising, the ALS Association, finances...

California Stem Cell Report
California Draws Good Card on $39 Million Stem Cell Diabetes Effort

California’s $39 million bet on a new stem cell therapy for diabetes today moved a notch ahead today with word that the treatment's developer has received federal approval to begin a clinical trial.


“Very encouraging news” was how the new president of the state stem cell agency, Randy Mills, described the announcement by Viacyte, Inc. “Exciting” was...

California Stem Cell Report
‘De-risking’ Stem Cell Therapy with Government Cash and Assistance

‘De-risking’ Stem Cell Therapy with Government Cash and Assistance

Nature Biotechnology this month took a crack at what it called “therapies of the state,” three government- financed efforts at turning stem cells into cures.


The piece by Beth Schachter discussed “thorny technical challenges,” safety issues and regulatory and IP risk – not to mention the dreaded “reimbursement” risk. (Reimbursement is a PR...

California Stem Cell Report
Scientist/Parkinson’s Advocate With Biotech Background Appointed to California Stem Cell Agency Board

Scientist/Parkinson’s Advocate With Biotech Background Appointed to California Stem Cell Agency Board

A retired San Diego scientist with a background in the biotech industry was named this week to the 29-member governing board of the $3 billion California stem cell agency.


David Higgins
Parkinson's Association photo
David Higgins, who is also president of the San Diego Parkinson’s Association, was appointed by State...

California Stem Cell Report
$40 Million California Stem Cell Genomics Agreement Signed; A Checkered Past

Aug 11, 2014

The California stem cell agency and a Stanford-led consortium have reached agreement on a $40 million stem cell genomics project that triggered complaints about irregularities, unfairness, score manipulation and the role of its then president, Alan Trounson.


The agreement was concluded last month with Stanford, UC Santa Cruz and the Salk Institute in La Jolla,...

California Stem Cell Report
Another Perspective on the Trounson Flap: Columnist Lists It as Example of ‘Possible Corruption’

The $3 billion California stem cell agency was mixed up with some bad company this week – part of the fallout from last month’s Trounson Affair. 


The agency was lumped together with some ne’er-do-wells in a column in California newspapers that was headlined:

“California state government awash in corruption, conflict of interest”
The piece was...

California Stem Cell Report
The New, Official Life Expectancy of the California Stem Cell Agency

The New, Official Life Expectancy of the California Stem Cell Agency

Randy Mills' calculations on cash for future CIRM funding

Randy Mills, the new president of the $3 billion California stem cell agency, rewrote some of the agency’s history last week and extended the life span of the now nearly 10-year-old enterprise.


All that talk about the agency...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook  Sign up for the Sacramento Connect Newsletter

Advertisement

Categories

  • Hot Topics (2)
  • Shopping (791)
  • Top Stories (3423)

Advertisement